Canadian Critical Paths
Key Steps for Success in Canadian Pharma
The international healthcare landscape is constantly changing, and organizations need specialized guidance to enter any new marketplace. For companies looking to establish a business in Canada, the healthcare industry and delivery system must be approached like ten countries in one—each province has a different set of rules. So where do you start?
Pangaea can help make the path clear. Our knowledge and critical path planning behind your project means you can get your business established in Canada, and successfully position and optimally manage products within each province.
The Team at PANGAEA is a pleasure to work with, consummate and diverse professionals with solid breadth and depth in the Pharmaceutical / Health Care industry. PANGAEA drives forward thinking … a key to success in this dynamic and ever-changing business. For the future, opportunities to work with the team are being created each time we meet. Pangaea is a strategic partner in our business, helping us guide our key stakeholder / customer relations. As an aside, Joe’s handicap – I would think it would be lower.
Michael Charbonneau, VP Specialty Products Business Unit, Valeant Canada Limited
Corporate Start-Up Critical Path
Newcomer to the marketplace? Let us guide you with brand and marketing planning, sales force requirements, trade logistics and corporation setup.
What you get
- Analysis of your therapeutic areas of interest so we can develop your customized critical path
- Review of all aspects of commercialization for a broad view of your project:
- Filing and approval
- Market access
- SAP and distribution, marketing, and KOL development
- Corporate deployment
- A detailed critical path, from Importer of Record, 3PL and Establishment License, Terms and Conditions for Sale through to deployment strategies, to kickstart your Canadian organization
Learn more about marketing and sales training
Brand Launch Critical Path
Launching a new brand? We can help you successfully bring a new product to the primary, oncology or specialty care market.
What you get
- Key milestones for an at-a-glance overview of what’s next
- Gap identification report to ensure activities and timing do not affect critical milestones
- Comparative benchmarks and expert perspective on critical steps and time to completion, for an up-to-the-minute view of your position in the evolving Canadian healthcare system
Loss of Exclusivity Critical Path
Facing loss of exclusivity (LOE)? We can help you delay LOE or maintain revenue after LOE.
What you get
- Key milestones for a quick, clear view of what you need to do
- In-depth critical steps report with details on timing and activity gaps
- Expert benchmarks perspective report on critical steps and current time-to-complete for all therapeutic components: Narrow therapeutic index, biosimilars and normal API products